Situación actual de la hepatitis B en Chile

Background: Hepatitis B virus infection generates carriers and 8% will evolve to a chronic phase. Aim: To perform a compilation of studies on hepatitis B in Chile and other sources of information to estímate the impact of this disease in our country. Material and methods: Published and unpublished e...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Pereira S,Ana, Valenzuela B,María Teresa, Mora,Judith, Vera,Lilian
Lenguaje:	Spanish / Castilian
Publicado:	Sociedad Médica de Santiago 2008
Materias:	Hepatitis B Hepatitis B virus surface antigen P31c HIV
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872008000600006
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:scielo:S0034-98872008000600006
record_format	dspace
spelling	oai:scielo:S0034-988720080006000062008-08-26Situación actual de la hepatitis B en ChilePereira S,AnaValenzuela B,María TeresaMora,JudithVera,Lilian Hepatitis B Hepatitis B virus surface antigen P31c HIV Background: Hepatitis B virus infection generates carriers and 8% will evolve to a chronic phase. Aim: To perform a compilation of studies on hepatitis B in Chile and other sources of information to estímate the impact of this disease in our country. Material and methods: Published and unpublished evidence about the infection, in the general population and risk groups in our country, was compiled and reviewed critically. Informal interviews to experts, revisión of the mandatory notification book of the Ministry of Health and collection of data from ¡aboratories that study hepatitis B virus, were also carried out. Results: The seroprevalence of chronic carriers in blood donors is nearly O.3%. Among risk groups such as health care personnel, the figure is O.7%, among homosexuals 29%, among HIV positive patients 30%, among sexual workers 2% and among children with chronic hemodialysis, 9%. Prevalence rate according to notified cases in 2004 was 1.8 x 100,000 habitants. Detection of viral hepatitis B surface antigen in ¡aboratories occurs in 0.2% of donors and 1.396 of non donors. Conclusions: The seroprevalence of hepatitis B virus, the lack of notification, and the introduction of hepatitis B vaccine to our Regular Program of Immunizations, are arguments to develop in Chile a hepatitis B and C surveillance systeminfo:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.136 n.6 20082008-06-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872008000600006es10.4067/S0034-98872008000600006
institution	Scielo Chile
collection	Scielo Chile
language	Spanish / Castilian
topic	Hepatitis B Hepatitis B virus surface antigen P31c HIV
spellingShingle	Hepatitis B Hepatitis B virus surface antigen P31c HIV Pereira S,Ana Valenzuela B,María Teresa Mora,Judith Vera,Lilian Situación actual de la hepatitis B en Chile
description	Background: Hepatitis B virus infection generates carriers and 8% will evolve to a chronic phase. Aim: To perform a compilation of studies on hepatitis B in Chile and other sources of information to estímate the impact of this disease in our country. Material and methods: Published and unpublished evidence about the infection, in the general population and risk groups in our country, was compiled and reviewed critically. Informal interviews to experts, revisión of the mandatory notification book of the Ministry of Health and collection of data from ¡aboratories that study hepatitis B virus, were also carried out. Results: The seroprevalence of chronic carriers in blood donors is nearly O.3%. Among risk groups such as health care personnel, the figure is O.7%, among homosexuals 29%, among HIV positive patients 30%, among sexual workers 2% and among children with chronic hemodialysis, 9%. Prevalence rate according to notified cases in 2004 was 1.8 x 100,000 habitants. Detection of viral hepatitis B surface antigen in ¡aboratories occurs in 0.2% of donors and 1.396 of non donors. Conclusions: The seroprevalence of hepatitis B virus, the lack of notification, and the introduction of hepatitis B vaccine to our Regular Program of Immunizations, are arguments to develop in Chile a hepatitis B and C surveillance system
author	Pereira S,Ana Valenzuela B,María Teresa Mora,Judith Vera,Lilian
author_facet	Pereira S,Ana Valenzuela B,María Teresa Mora,Judith Vera,Lilian
author_sort	Pereira S,Ana
title	Situación actual de la hepatitis B en Chile
title_short	Situación actual de la hepatitis B en Chile
title_full	Situación actual de la hepatitis B en Chile
title_fullStr	Situación actual de la hepatitis B en Chile
title_full_unstemmed	Situación actual de la hepatitis B en Chile
title_sort	situación actual de la hepatitis b en chile
publisher	Sociedad Médica de Santiago
publishDate	2008
url	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872008000600006
work_keys_str_mv	AT pereirasana situacionactualdelahepatitisbenchile AT valenzuelabmariateresa situacionactualdelahepatitisbenchile AT morajudith situacionactualdelahepatitisbenchile AT veralilian situacionactualdelahepatitisbenchile
_version_	1718436383252545536

Situación actual de la hepatitis B en Chile

Ejemplares similares